Illinois law protects 340B providers' access to pharmacy partners and requires annual reporting, with some provider groups starting in 2029.
People and drug makers may not block Illinois 340B providers from getting covered drugs or choosing pharmacy partners, unless federal law bars the drug receipt.
People and drug makers may not demand extra 340B pricing or program data, or impose added inventory rules, unless state or federal law requires them.
340B providers must report program and patient-care information each year; some small and safety-net providers start in 2029. The state must report Medicaid drug use and costs by 2028.
Each 340B provider may use a drug only for outpatient care the patient received in the past 18 months and must prevent, and repay, duplicate discounts.
People and drug makers may not block covered providers from getting 340B drugs or choosing pharmacies to dispense them. This applies to Illinois entities in the federal 340B drug discount program and pharmacies they hire to dispense the drugs, including qualifying pharmacies outside Illinois. A drug receipt may be blocked when federal law prohibits it. The law does not apply in a way that conflicts with federal law; required limits on distribution of certain drugs are not violations. The law took effect August 7, 2026.
People and drug makers may not require covered providers or their pharmacy partners to provide certain information or follow extra inventory rules. These limits apply to 340B covered entities and pharmacies dispensing 340B drugs for them. They may not demand 340B drug pricing or other information unless state or federal law requires it. They may not impose inventory management rules, including extra audits, unless a state or federal agency requires them. The law took effect August 7, 2026.
Covered entities must report on their 340B programs, and the state health department must report on Medicaid drug use and costs. The annual reporting duty covers 340B covered entities. The department's report covers outpatient drugs dispensed or given through Illinois Medicaid, by fee-for-service and each managed care plan. The annual reports include program recertification, charity care information when required, drug costs and payments, claims, audits, and effects on patients and communities. Hospitals with fewer than 100 licensed beds, Critical Access Hospitals, Safety-Net Hospitals, and 340B grantees are exempt until January 1, 2029. If the department lacks a required Medicaid data item, it must estimate it reasonably and explain what information is missing. Most provider reports are due each August 1 starting in 2026; the exempt groups begin August 1, 2029. The department's report is due January 1, 2028.
Each covered entity must limit 340B drug use to recent outpatient care and maintain a policy to prevent duplicate discounts. These duties apply to each 340B covered entity in Illinois. A provider may dispense or give a 340B drug only for outpatient care the patient received within the prior 18 months. The policy must prevent ordering replacement drugs when another covered entity will replenish the same pharmacy dispense, and must include a process to repay manufacturers for duplicate discounts received. Each provider must file its policy with the General Assembly every year; the law took effect August 7, 2026.
No hearings or votes scheduled.